Drug shortage: Methylphenidate Hydrochloride Tablet, Extended Release (CONCERTA, METHYLPHENIDATE HYDROCHLORIDE, RELEXXII)
FDA lists 34 presentations as Current. Availability: Unavailable (6), Limited Availability (9), Available (19). Reason: Demand increase for the drug; Other. Companies: Janssen Pharmaceuticals, Trigen Laboratories, LLC, Lannett Company, Inc., Vertical Pharmaceuticals, LLC, Teva Pharmaceuticals USA, Inc.….
- Published by source
- 2023-07-26
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Janssen Pharmaceuticals
- Products
- Methylphenidate Hydrochloride Tablet, Extended Release CONCERTA METHYLPHENIDATE HYDROCHLORIDE RELEXXII
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Allocation to current contracted customers
- Estimated recovery: November 2026
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-07-26
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #922 | new | 2026-10-22 | e2afc27c91f1…db384c | 30ed44dfea6c…c061bc |
| #1124 | update | 2026-10-23 | f1169f22217d…8c412a | dd57ddfbffe0…a39938 |
| #1358 | update | 2026-10-23 | e5e74b651c20…3a2bc5 | fdaa13d8dbba…7aa0c1 |
Chain head: #1479 ad3417dbc128…777bd4